179 related articles for article (PubMed ID: 38551584)
21. Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype.
Longhitano L; Giallongo S; Orlando L; Broggi G; Longo A; Russo A; Caltabiano R; Giallongo C; Barbagallo I; Di Rosa M; Giuffrida R; Parenti R; Li Volti G; Vicario N; Tibullo D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613471
[TBL] [Abstract][Full Text] [Related]
22. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
Zhu P; Jin Z; Kang G; Jia Y; Liu D; Zhang Q; Guo F; Jia Y; Jiao Y; Li J; Sun H; Ma X
Cell Commun Signal; 2022 Aug; 20(1):121. PubMed ID: 35971127
[TBL] [Abstract][Full Text] [Related]
23. HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma.
Sriramareddy SN; Faião-Flores F; Emmons MF; Saha B; Chellappan S; Wyatt C; Smalley I; Licht JD; Durante MA; Harbour JW; Smalley KSM
Cancer Gene Ther; 2022 Dec; 29(12):1840-1846. PubMed ID: 35332245
[TBL] [Abstract][Full Text] [Related]
24. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
25. STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling.
Zhou X; Meng F; Xu B; Ma R; Cheng Y; Wu J; Qian J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099424
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis.
Shi S; Chen H; Wang H; Wan J; Shi Y; Li J; Wang S; Shi J; Lv J; Wu T; Wang L; Sun F
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3349-3360. PubMed ID: 35941228
[TBL] [Abstract][Full Text] [Related]
27. Autocrine impact of VEGF-A on uveal melanoma cells.
Koch KR; Refaian N; Hos D; Schlereth SL; Bosch JJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2697-704. PubMed ID: 24677103
[TBL] [Abstract][Full Text] [Related]
28. The biology of uveal melanoma.
Amaro A; Gangemi R; Piaggio F; Angelini G; Barisione G; Ferrini S; Pfeffer U
Cancer Metastasis Rev; 2017 Mar; 36(1):109-140. PubMed ID: 28229253
[TBL] [Abstract][Full Text] [Related]
29. Melanoma subtypes demonstrate distinct PD-L1 expression profiles.
Kaunitz GJ; Cottrell TR; Lilo M; Muthappan V; Esandrio J; Berry S; Xu H; Ogurtsova A; Anders RA; Fischer AH; Kraft S; Gerstenblith MR; Thompson CL; Honda K; Cuda JD; Eberhart CG; Handa JT; Lipson EJ; Taube JM
Lab Invest; 2017 Sep; 97(9):1063-1071. PubMed ID: 28737763
[TBL] [Abstract][Full Text] [Related]
30. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
31. Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways.
Liu S; Chen L; Chen H; Xu K; Peng X; Zhang M
J Exp Clin Cancer Res; 2021 Feb; 40(1):66. PubMed ID: 33579337
[TBL] [Abstract][Full Text] [Related]
32. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
[TBL] [Abstract][Full Text] [Related]
33. Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma.
Han A; Chua V; Baqai U; Purwin TJ; Bechtel N; Hunter E; Tiago M; Seifert E; Speicher DW; Schug ZT; Harbour JW; Aplin AE
Oncogene; 2022 Feb; 41(8):1129-1139. PubMed ID: 35046531
[TBL] [Abstract][Full Text] [Related]
34. The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.
Chua V; Han A; Bechtel N; Purwin TJ; Hunter E; Liao C; Harbour JW; Aplin AE
Pigment Cell Melanoma Res; 2022 Jan; 35(1):78-87. PubMed ID: 34347929
[TBL] [Abstract][Full Text] [Related]
35. Uveal melanoma as a target for immune-therapy.
Oliva M; Rullan AJ; Piulats JM
Ann Transl Med; 2016 May; 4(9):172. PubMed ID: 27275485
[TBL] [Abstract][Full Text] [Related]
36. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
[TBL] [Abstract][Full Text] [Related]
37. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
[TBL] [Abstract][Full Text] [Related]
38. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma.
Klisovic DD; Klisovic MI; Effron D; Liu S; Marcucci G; Katz SE
Melanoma Res; 2005 Jun; 15(3):147-53. PubMed ID: 15917695
[TBL] [Abstract][Full Text] [Related]
39. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
40. Functional significance of B7-H1 expressed by human uveal melanoma cells.
Jia R; Jiao Z; Xu X; Wang J; Zhou Y; Song X; Ge S; Fan X
Mol Med Rep; 2011; 4(1):163-7. PubMed ID: 21461580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]